Oculis Holding AG (OCS) Net Cash Flow Growth (1y) (2023 - 2026)
Oculis Holding AG (OCS) Net Cash Flow Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 37.58 Bn | 34.57 Bn | 959.66 Mn | 53.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.82% |
| Dec 31, 2025 | 1,030.89% |
| Sep 30, 2025 | -41.85% |
| Jun 30, 2025 | -189.43% |
| Mar 31, 2025 | 628.29% |
| Dec 31, 2024 | -187.95% |
| Sep 30, 2024 | 23.19% |
| Jun 30, 2024 | -0.21% |
| Mar 31, 2024 | -120.75% |
| Dec 31, 2023 | 219.38% |
| Sep 30, 2023 | -205.76% |